Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025

# Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025 **What the Bill Would Do** This bill, formally titled the Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) Act, aims to speed up access to medical treatments by allowing drugs and therapies approved in other countries to be used in the United States without waiting for full FDA approval. The core idea is to create a "reciprocity" system where treatments already deemed safe and effective by trusted foreign regulatory agencies—such as those in Canada, Australia, or European nations—could become available to American patients more quickly. **Who It Affects and Key Provisions** The bill primarily affects patients with serious or life-threatening conditions who might benefit from treatments currently unavailable in the U.S., as well as pharmaceutical companies and medical device manufacturers. By recognizing approvals from other countries' regulatory agencies, the bill could reduce the time and cost for getting new treatments to market.

However, specific details about which countries would qualify, oversight mechanisms, and safety standards are not provided in this summary. **Current Status** As of now (119th Congress), the bill is in committee and has not yet been voted on by the full Senate. It was introduced by Senator Ted Cruz (R-TX).